Get the free INVESTIGATIONAL NEW DRUG APPLICATION (IND) - ucdenver

Reset Form. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Food and Drug Administration. INVESTIGATIONAL NEW DRUG APPLICATION (IND).

How to fill out investigational new drug application

How to fill out an investigational new drug application:

1. Obtain the necessary forms: Start by obtaining the required forms for the investigational new drug (IND) application. These forms can be obtained from the regulatory authority, such as the Food and Drug Administration (FDA) in the United States.
2. Gather essential information: Before starting to fill out the application, gather all the necessary information about the drug. This includes preclinical data, manufacturing details, proposed clinical trials, safety and efficacy data, and any other relevant information.
3. Fill out the administrative sections: The application will require administrative information such as the drug's proprietary name, chemical name, dosage form, route of administration, and the name and contact details of the sponsor or applicant. Fill out these sections accurately.
4. Provide a summary of the drug: Write a concise summary of the drug, describing its background, purpose, and intended use. Include information on the drug's mechanism of action and any previous research or clinical experience.
5. Include preclinical data: Provide detailed preclinical data from animal studies or in vitro experiments. This data should demonstrate the drug's safety, effectiveness, and potential risks.
6. Submit manufacturing details: Include comprehensive manufacturing details, including the drug's composition, formulation, manufacturing process, quality control measures, and any relevant certifications or licenses.
7. Detail the proposed clinical trials: Describe the planned clinical trials, including the study design, objectives, patient selection criteria, and monitoring procedures. Provide information on the number of patients, duration of the trials, and any ethical considerations.
8. Present safety and efficacy data: Include any available safety and efficacy data from previous clinical trials, if applicable. This information should support the hypothesis that the drug has a beneficial effect and is safe for use in humans.
9. Provide additional information: If there is any further relevant information, such as drug-drug interactions, pharmacokinetics, or special populations, include it in the application.

Who needs an investigational new drug application?

1. Pharmaceutical companies: Pharmaceutical companies developing new drugs or therapeutic agents need to submit an investigational new drug application. This allows them to conduct clinical trials to evaluate the drug's safety and efficacy before seeking approval for commercial marketing.
2. Researchers and academia: Researchers working in the field of drug development or clinical trials may require an investigational new drug application to legally test and study new drugs or investigational compounds.
3. Contract research organizations (CROs): CROs involved in conducting clinical trials on behalf of pharmaceutical companies or research institutions also require the submission of investigational new drug applications to gain regulatory permission for the trials.
4. Biotechnology companies: Companies in the biotechnology sector, which focus on developing new and innovative therapies, often need to submit investigational new drug applications as part of their drug development process.
5. Government agencies: Regulatory authorities, such as the FDA in the United States or the European Medicines Agency (EMA) in the European Union, require investigational new drug applications for review and approval before clinical trials can be conducted.

It is important to consult the specific regulations and guidelines of the regulatory authority in your country when filling out an investigational new drug application, as the requirements may vary.

For pdfFiller’s FAQs

How do I edit investigational new drug application in Chrome?

Get and add pdfFiller Google Chrome Extension to your browser to edit, fill out and eSign your investigational new drug application, which you can open in the editor directly from a Google search page in just one click. Execute your fillable documents from any internet-connected device without leaving Chrome.

Can I sign the investigational new drug application electronically in Chrome?

Yes. You can use pdfFiller to sign documents and use all of the features of the PDF editor in one place if you add this solution to Chrome. In order to use the extension, you can draw or write an electronic signature. You can also upload a picture of your handwritten signature. There is no need to worry about how long it takes to sign your investigational new drug application.

Can I create an electronic signature for signing my investigational new drug application in Gmail?

You may quickly make your eSignature using pdfFiller and then eSign your investigational new drug application right from your mailbox using pdfFiller's Gmail add-on. Please keep in mind that in order to preserve your signatures and signed papers, you must first create an account.

What is investigational new drug application?

An investigational new drug application (IND) is a request for authorization from the FDA to administer an investigational drug or biological product to humans.

Who is required to file investigational new drug application?

Sponsors or sponsors-investigators who plan to conduct clinical trials with investigational drugs must file an IND.

How to fill out investigational new drug application?

The IND application must contain information on the drug's chemistry, manufacturing, and controls, preclinical data, proposed clinical protocols, and investigator information.

What is the purpose of investigational new drug application?

The purpose of an IND is to ensure the safety and rights of human participants in clinical trials, as well as the quality and integrity of the data collected.

What information must be reported on investigational new drug application?

The IND must include information on the drug's pharmacology, toxicology, pharmacokinetics, and proposed clinical use.